Marc Righini
Marc Righini publishes mostly in Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Blood Coagulation and Thrombosis Mechanisms.
- World rank
- #167,677 of 7,710,434 ranked researchers
- Rank in Switzerland
- #3,397 of 80,918
- Works
- 701
- Citations
- 33k
- Citations per work
- 47.1
What does Marc Righini research?
Marc Righini's work is mostly in Medicine (69%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences48268.8%
- Medicine48268.8%
- Everything else21931.2%
- 1Internal Medicine24% of their works
- 2Cardiology and Cardiovascular Medicine13% of their works
- 3Surgery13% of their works
- 4Epidemiology6% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Hematology6% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Diagnosis and Treatment of Venous Diseases
- Acute Ischemic Stroke Management
- Central Venous Catheters and Hemodialysis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Ultrasound in Clinical Applications
Which keywords describe Marc Righini's research?
The keywords of their largest research topics: Antithrombotic Therapy, Clinical Practice Guidelines, Risk Factors, Diagnosis, Pulmonary Embolism, Venous Thromboembolism, Anticoagulant Therapy and Atrial Fibrillation.
- Point-of-Care Ultrasonography
- Thrombosis
- Central Venous Catheterization
- Thrombolysis
- Varicose Veins
- Thrombin
- Atrial Fibrillation
- Venous Thromboembolism
- Diagnosis
- Clinical Practice Guidelines
- Antithrombotic Therapy
- Risk Factors
- Pulmonary Embolism
- Anticoagulant Therapy
- Protease-Activated Receptors
- Chronic Venous Insufficiency
- Ischemic Stroke
- Catheter-Related Infections
- Heparin-Induced Thrombocytopenia
- Lung Ultrasound
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antithrombotic Therapy4972 topics
- Clinical Practice Guidelines4932 topics
- Risk Factors4822 topics
- Diagnosis4612 topics
- Pulmonary Embolism4171 topic
- Venous Thromboembolism4171 topic
- Anticoagulant Therapy1341 topic
- Atrial Fibrillation1341 topic
- Protease-Activated Receptors801 topic
- Thrombin801 topic
- Chronic Venous Insufficiency761 topic
- Varicose Veins761 topic
- Ischemic Stroke651 topic
- Thrombolysis651 topic
- Catheter-Related Infections531 topic
- Central Venous Catheterization531 topic
- Heparin-Induced Thrombocytopenia441 topic
- Thrombosis441 topic
- Lung Ultrasound401 topic
- Point-of-Care Ultrasonography401 topic
Where does Marc Righini work?
Marc Righini's main affiliation in the publication record is University Hospital of Geneva, Switzerland.
How many publications and citations does Marc Righini have?
OpenAlex counts 701 works and 33,004 citations for Marc Righini, an h-index of 75, ranking #167,677 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marc Righini. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.